Direxion Daily S&P Biotech Bull and Bear 3X Shares
The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
Investing in a Direxion Shares ETF may be more volatile than investing in broadly diversified funds. The use of leverage by the Fund increases the risk to the Fund. The Direxion Shares ETFs are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk and the consequences of seeking daily leveraged investment results and intend to actively monitor and manage their investment.
LABU
LABD
Operational Updates
- 01/23/2024
Direxion's New ETF Alert Service. Get Price and Volume Alerts automatically via text message!
Set Up Your ETF Alerts Today - 11/06/2023
Direxion Announces Reverse Splits of TMF and LABU
Read the Article
Documents & Downloads
These leveraged ETFs seek a return that is 300% or -300% of the return of their benchmark index for a single day. The funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day.
Pricing & Performance
NAV and Market Price information as of 12/03/2024.
Net Asset Value (NAV)
Market Price Closing
Net Asset Value (NAV)
Market Price Closing
1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Expense Ratio* (Gross / Net%) | Inception Date | |
---|---|---|---|---|---|---|---|---|---|---|
LABU NAV | 4.83 | -11.18 | 3.00 | 63.47 | -47.00 | -35.19 | — | -28.75 | 0.96 / 0.96* | 05/28/2015 |
LABU Market Close | 4.98 | -11.00 | 3.19 | 63.32 | -47.03 | -35.17 | — | -28.74 | 0.96 / 0.96* | 05/28/2015 |
LABD NAV | -9.89 | 2.46 | -40.88 | -65.92 | -38.32 | -53.08 | — | -52.97 | 1.12 / 1.10* | 05/28/2015 |
LABD Market Close | -9.92 | 2.07 | -41.11 | -66.06 | -38.39 | -53.14 | — | -52.99 | 1.12 / 1.10* | 05/28/2015 |
As of November 30, 2024
The Primary Listing Exchange is the NYSE Arca, Inc.
*The Net Expense Ratio includes management fees, other operating expenses and Acquired Fund Fees and Expenses. If Acquired Fund Fees and Expenses were excluded, the Net Expense Ratio would be 0.92% for LABU and 0.95% for LABD. The Funds’ adviser, Rafferty Asset Management, LLC (“Rafferty”), has entered into an Operating Expense Limitation Agreement with each Fund. Under the Operating Expense Limitation Agreement, Rafferty has contractually agreed to waive all or a portion of its management fee and/or reimburse the Funds for Other Expenses through September 1, 2025, to the extent that a Fund’s Total Annual Fund Operating Expenses exceed 0.95% of the Fund’s average daily net assets (excluding, as applicable, among other expenses, taxes, swap financing and related costs, acquired fund fees and expenses, dividends or interest on short positions, other interest expenses, brokerage commissions and extraordinary expenses). If these expenses were included, the expense ratio would be higher.
Short-term performance, in particular, is not a good indication of a fund’s future performance, and an investment should not be made based solely on returns. Because of ongoing market volatility, fund performance may be subject to substantial short-term changes. For additional information, see the fund’s prospectus.
Index Information
The S&P Biotechnology Select Industry Index (SPSIBITR) is provided by S&P Dow Jones Indices LLC and includes domestic companies from the biotechnology industry. The Index is a modified equal-weighted index that is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). One cannot invest directly in an index.
Index Top Ten Holdings
% of Total | |
---|---|
Utd Therapeut | 2.68% |
Incyte | 2.63% |
Exact Sciences | 2.63% |
Alnylam Pharmaceuticals | 2.63% |
Abbvie Shares | 2.58% |
Gilead Sciences | 2.56% |
Natera Shares | 2.54% |
Sarepta Therapeutics Inc De | 2.54% |
Biogen Inc | 2.51% |
Moderna Inc | 2.48% |
Index Sector Weightings
% of Total | |
---|---|
Biotechnology | 100.00% |
Strategy and Benefits
You know that TRADING is different than investing. But the opportunity to take advantage of short-term trends is only won, if you get the direction right.
Whether you’re a bull or a bear, Direxion is with you. Our leveraged ETFs are powerful tools built to help you:
- Magnify your short-term perspective with daily 3X leverage
- Go where there’s opportunity, with bull and bear funds for both sides of the trade; and
- Stay agile – with liquidity to trade through rapidly changing markets
Leveraged and inverse ETFs pursue daily leveraged investment objectives which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying index over periods longer than one day. They are not suitable for all investors and should be utilized only by investors who understand leverage risk and who actively manage their investments.
Distributions
LABU Direxion Daily S&P Biotech Bull 3X Shares
Record Date | Ex Date | Pay Date | Income Dividend | Short-Term Capital Gain | Long-Term Capital Gain | Expand |
---|---|---|---|---|---|---|
06/25/2024 | 06/25/2024 | 07/02/2024 | 0.15021 | — | — | |
03/20/2024 | 03/19/2024 | 03/26/2024 | 0.16064 | — | — | |
12/22/2023 | 12/21/2023 | 12/29/2023 | 0.20968 | — | — | |
09/20/2023 | 09/19/2023 | 09/26/2023 | 0.00202 | — | — | |
Record Date06/25/2024 Ex Date06/25/2024 Pay Date07/02/2024 Income Dividend0.15021 Short-Term Capital Gain— Long-Term Capital Gain— Record Date03/20/2024 Ex Date03/19/2024 Pay Date03/26/2024 Income Dividend0.16064 Short-Term Capital Gain— Long-Term Capital Gain— Record Date12/22/2023 Ex Date12/21/2023 Pay Date12/29/2023 Income Dividend0.20968 Short-Term Capital Gain— Long-Term Capital Gain— Record Date09/20/2023 Ex Date09/19/2023 Pay Date09/26/2023 Income Dividend0.00202 Short-Term Capital Gain— Long-Term Capital Gain— |
LABD Direxion Daily S&P Biotech Bear 3X Shares
Record Date | Ex Date | Pay Date | Income Dividend | Short-Term Capital Gain | Long-Term Capital Gain | Expand |
---|---|---|---|---|---|---|
09/24/2024 | 09/24/2024 | 10/01/2024 | 0.05774 | — | — | |
06/25/2024 | 06/25/2024 | 07/02/2024 | 0.08904 | — | — | |
03/20/2024 | 03/19/2024 | 03/26/2024 | 0.06640 | — | — | |
12/22/2023 | 12/21/2023 | 12/29/2023 | 0.08463 | — | — | |
Record Date09/24/2024 Ex Date09/24/2024 Pay Date10/01/2024 Income Dividend0.05774 Short-Term Capital Gain— Long-Term Capital Gain— Record Date06/25/2024 Ex Date06/25/2024 Pay Date07/02/2024 Income Dividend0.08904 Short-Term Capital Gain— Long-Term Capital Gain— Record Date03/20/2024 Ex Date03/19/2024 Pay Date03/26/2024 Income Dividend0.06640 Short-Term Capital Gain— Long-Term Capital Gain— Record Date12/22/2023 Ex Date12/21/2023 Pay Date12/29/2023 Income Dividend0.08463 Short-Term Capital Gain— Long-Term Capital Gain— |
Documents
Tax Documents
Download the following Tax Reporting Documents
- Form 8937
(LABD 2020)
How to Trade
ETFs are generally available for purchase on exchanges, much like stocks—and can be bought and sold throughout the trading day whenever exchanges are open. Direxion ETFs cannot be purchased directly from Direxion, but are available for trading on most trading platforms.
We strongly recommend that you take the time to educate yourself on how leveraged and inverse ETFs function and behave in various market conditions before you endeavor to trade them in your account. It’s always a good idea to consult a financial advisor or brokerage account representative if you have questions about any ETFs.
Please note, your advisor or broker may charge commissions or other transaction fees. If you have any questions specific to Direxion products, please contact us direct at [email protected] or 866-476-7523.
Operational Updates
- 01/23/2024
Direxion's New ETF Alert Service. Get Price and Volume Alerts automatically via text message!
Set Up Your ETF Alerts Today - 11/06/2023
Direxion Announces Reverse Splits of TMF and LABU
Read the Article
Documents & Downloads
How to Trade
While you can't trade our funds from our website, investors still have multiple options for buying Direxion ETFs
Learn More About Trading Direxion ETFs
What's Inside?
Browse Other Funds
Subscribe to Newsletters & Operational Updates
Sign up for email and/or text of the important news, including:
- Fund updates including splits, distributions, launches, and other corporate actions
- Educational events, such as web seminars and conferences
- Our latest research and industry trends
Learn About Leveraged & Inverse ETFs
Trading is different than investing. Use our insights and educational resources to make sure you’re ready to trade in Direxion’s Leveraged and Inverse ETFs.